You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Type 2 Issues Articles
Popular Type 2 Issues Articles
Highly Recommended Type 2 Issues Articles
Send a link to this page to your friends and colleagues.
Obesity has always been one of the major precursors to type 2 diabetes because of its ill effects on the body's ability to properly use insulin. But until now, scientists haven't been able to say with certainty just what happens in obese people to increase their insulin resistance.
Now scientists from Monash University in Melbourne, Australia, think they have an answer: a protein released by fat cells that desensitizes the liver and muscles to insulin. A large presence of the protein, called PEDF (pigment epithelium-derived factor), forces the pancreas to produce more insulin to counter the desensitization. Eventually, however, the pancreas becomes overworked, either slowing down dramatically or entirely stopping insulin production, which leads to type 2 diabetes.
Obese people, because they have more fat cells, produce more PEDF, thus increasing their chances of acquiring diabetes through a combination of insulin desensitization and stress on the pancreas.
The Australian researchers found that increasing PEDF levels in the bloodstream led to type 2 symptoms, while suppressing the protein reversed the effect and returned blood glucose levels and insulin sensitivity to normal levels.
Now that scientists have a clear link between obesity and the onset of type 2, the way is open for the development of drugs designed to control PEDF and sever that link.
The Monash team published its findings in the July 8 edition of Cell Metabolism.
0 comments - Jul 14, 2009
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.